New patent issued for core rare disease target indication for crofelemerJaguar is supporting investigator-initiated proof-of-concept studies of crofelemer for the rare disease indications of SBS and microvillus inclusion
KULR Technology Group Inc (NASDAQ: KULR) shares are gaining after the company announced a development contract from a United States Armed Forces branch to develop battery packs for uninterruptible power supplies to
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.